EUVIMEDEUVIMED entdecken
Open Access

Partial Splenic Embolization for Portal Hypertension Exacerbation During Atezolizumab/Bevacizumab Combination Therapy in Unresectable Hepatocellular Carcinoma

Toru Ishikawa, Nanako Terai, Ryo Sato, Hiroki Natsui, Takahiro Iwasawa, Masahiro Ogawa, Yuji Kobayashi, Toshifumi Sato, Junji Yokoyama, Akihiko Iiduka, Terasu Honma

In Vivo · 2025

DOI: 10.21873/invivo.13898 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Vivo, 2025. Verfasst von Toru Ishikawa und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Japan; toruishi@ngt.saiseikai.or.jp. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Embolization, Therapeutic, Hypertension, Portal. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsEmbolization, TherapeuticHypertension, PortalAntineoplastic Combined Chemotherapy ProtocolsHumansBevacizumabAntibodies, Monoclonal, HumanizedMaleMiddle AgedFemaleAgedTreatment OutcomeCombined Modality TherapySpleen

Stichwörter der Autor:innen

Atezolizumab/bevacizumab combination therapyhepatocellular carcinomaimmune boostpartial splenic embolizationportal hypertension

Substanzen

BevacizumabatezolizumabAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Department of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Japan; toruishi@ngt.saiseikai.or.jp.
  • Department of Radiology, Saiseikai Niigata Hospital, Niigata, Japan.
  • Department of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Japan.

Zitieren

APA

Ishikawa, T., Terai, N., Sato, R., Natsui, H., Iwasawa, T., Ogawa, M., Kobayashi, Y., Sato, T., Yokoyama, J., Iiduka, A., & Honma, T. (2025). Partial Splenic Embolization for Portal Hypertension Exacerbation During Atezolizumab/Bevacizumab Combination Therapy in Unresectable Hepatocellular Carcinoma. In Vivo. https://doi.org/10.21873/invivo.13898

Vancouver

Ishikawa T, Terai N, Sato R, Natsui H, Iwasawa T, Ogawa M, et al. Partial Splenic Embolization for Portal Hypertension Exacerbation During Atezolizumab/Bevacizumab Combination Therapy in Unresectable Hepatocellular Carcinoma. In Vivo. 2025. doi:10.21873/invivo.13898

BibTeX
@article{Ishikawa2025,
  author = {Ishikawa, Toru and Terai, Nanako and Sato, Ryo and Natsui, Hiroki and Iwasawa, Takahiro and Ogawa, Masahiro and Kobayashi, Yuji and Sato, Toshifumi and Yokoyama, Junji and Iiduka, Akihiko and Honma, Terasu},
  title = {Partial Splenic Embolization for Portal Hypertension Exacerbation During Atezolizumab/Bevacizumab Combination Therapy in Unresectable Hepatocellular Carcinoma},
  journal = {In Vivo},
  year = {2025},
  doi = {10.21873/invivo.13898}
}
Kostenlos starten →